REGENXBIO Inc.

RGNX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001590877

SEC filings (opens in a new tab)

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 0 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding REGENXBIO Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of RGNX: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	172	1	187	+16
Shares	35.5M	798	34.9M	−636.8K (−1.8%)
Value	$1.16B	$26.0K	$1.16B	−$4.03M (−0.3%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held REGENXBIO Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to RGNX in Q1 2022
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	517,267	$17.2M	0.08%
Jacobs Levy Equity Management, Inc	174,912	$5.80M	0.04%
American Century Companies Inc	47,997	$1.59M	0.00%
Trexquant Investment LP	42,655	$1.42M	0.07%
AQR Capital Management LLC	40,491	$1.34M	0.00%
Jump Financial, LLC	32,600	$1.08M	0.05%
Jennison Associates LLC	29,991	$995.0K	0.00%
Los Angeles Capital Management LLC	28,240	$937.0K	0.00%
Amalgamated Financial Corp.	17,854	$593.0K	0.00%
Public Employees Retirement System of Ohio	15,682	$520.0K	0.00%
Winton Group Ltd	14,199	$471.0K	0.02%
Two Sigma Advisers, LP	13,200	$438.0K	0.00%
Tudor Investment Corp Et Al	12,317	$409.0K	0.01%
Blueshift Asset Management, LLC	12,104	$402.0K	0.04%
Victory Capital Management Inc	14,224	$395.0K	0.00%
Two Sigma Investments, LP	11,600	$385.0K	0.00%
Algert Global LLC	11,073	$368.0K	0.02%
Gsa Capital Partners LLP	10,970	$364.0K	0.05%
HSBC Holdings PLC	9,533	$321.0K	0.00%
Gotham Asset Management, LLC	8,309	$276.0K	0.01%
Man Group plc	7,900	$262.0K	0.00%
Nkcfo LLC	3,500	$116.0K	0.04%
Baillie Gifford & Co	752	$25.0K	0.00%
Money Concepts Capital Corp	631	$21.0K	0.00%
Prospera Financial Services Inc	200	$7.00K	0.00%
TCI Wealth Advisors, Inc.	150	$5.00K	0.00%
Meeder Asset Management Inc	108	$4.00K	0.00%
EverSource Wealth Advisors, LLC	70	$2.00K	0.00%
Versant Capital Management, Inc	65	$2.00K	0.00%
TCWP LLC	37	$1.00K	0.00%
Quantbot Technologies LP	28	$0	0.00%
Global Retirement Partners, LLC	22	$0	0.00%

Sold out (16)

Institutions that held REGENXBIO Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of RGNX in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)	456,000	$14.9M
Frazier Management LLC	235,809	$7.71M
Carmignac Gestion	46,369	$1.52M
HighVista Strategies LLC	29,753	$973.0K
Duality Advisers, LP	22,301	$729.0K
Engineers Gate Manager LP	19,797	$647.0K
Voloridge Investment Management, LLC	13,372	$437.0K
Spearhead Capital Advisors, LLC	11,908	$389.0K
Cresset Asset Management, LLC	10,847	$354.0K
AlphaCrest Capital Management LLC	7,000	$229.0K
Advisors Asset Management, Inc.	4,682	$153.1K
Eaton Vance Management	597	$20.0K
Eagle Bay Advisors LLC	290	$9.00K
CWM, LLC	158	$5.00K
Signaturefd, LLC	55	$2.00K
Lenox Wealth Advisors, LLC	26	$1.00K

Not filed for Q1 2022 yet (1)

Institutions that held REGENXBIO Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RGNX in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
NEXT Financial Group, Inc	798	$26.0K